In vitro monitoring of picogram levels of captopril in human urine using flow injection chemiluminescence with immobilized reagent technique

Analytical Letters

Volumn 39, Issue 6, 2006, Pages 1115-1127

  Song, Zhenghua ^a   Hou, Shuang ^a   Yu, Xiangyang ^a   Xie, Xiaofeng ^a   Shao, Xiaodong ^a  

^a NORTHWEST UNIVERSITY   (China)

Author keywords

Captopril; Chemiluminescence; Co2+; Flow injection; Luminol

Indexed keywords

EID: 33646376501     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710600620567     Document Type: Article

References (18)

1. Bald, E. and Sypniewski, S. 1997. Determination of thiol drugs in pharmaceutical formulations as their 5-pyridinium derivatives by high-performance liquid chromatography with ultraviolet detection. Fresenius J. Anal. Chem., 358: 554-555.
2. Burdo, T.G. and Seitz, W.R. 1975. Mechanism of cobalt catalysis of luminol chemiluminescence. Anal. Chem., 47: 1639-1643.
3. The Captopril-Digoxin Multicenter Research Group. 1988. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA, 259: 539-544.
4. Cushman, D.W., Cheung, H.S., and Sabo, E.F. 1981. Angiotensin-Converting Enzyme Inhibitors; Horowitz, Z.P. (ed.); Urban and Schwarzenberg: Munich.
5. Du, J.X., Li, Y.H., and Lü, J.R. 2002. Flow injection chemiluminescence determination of captopril based in its enhancing effect in the luminol-ferricyanide/ferrocyanide reaction. Luminescence, 17: 165-167.
6. Economou, A., Themelis, D.G., Theodoridis, G.P., and Tzanavaras, P.D. 2002. Sensitive determination of captopril by flow injection analysis with chemiluminescence detection based on the enhancement of the luminol reaction. Anal. Chim. Acta, 463: 249-255.
7. Editorial Committee of the Pharmacopoeia of People's Republic of China. 2000. The Pharmacopoeia of People's Republic of China (Part II); Chemical Industry Press: Beijing.
8. El Reis, M.A., Abou Attia, F.M., and Kenawy, I.M.M. 2000. Indirect determination of captopril by AAS. J. Pharm. Biomed. Anal., 23: 249-254.
9. El-Ashry, S.M. and Ibrahim, F.A. 1992. Colorimetric determination of captopril in dosage forms. Anal. Lett., 25: 1657-1672.
10. Fraga, J.M.G., Abizanda, A.I.J., Moreno, F.J., and León, J.J.A. 1998. Application of principal component regression to the determination of captopril by differential pulse polarography with no prior removal of dissolved oxygen. Talanta, 46: 75-82.
11. 2+. Inflammopharmacology, 12: 289-303.
12. Huang, S.K. 1989. Comprehensive Textbook of Pharmacokinetics; Shanghai Medical University Press: Shanghai.
13. Kok, R.J., Visser, J., Moolenaar, F., de Zeeuw, D., and Meijer, D.K.F. 1997. Chromatographic identification of phenolic compounds in human urine following oral administration of the herbal medicines Daisaiko-to and Shosaiko-to. J. Chromatogr. B, 693: 191-189.
14. Merenyi, G., Lind, J., and Eriksen, T.E. 1990. Luminol chemiluminescence: Chemistry, excitation, emitter. J. Biolumin. Chemilumin., 5: 53-56.
15. Rose, A.L. and Waite, T.D. 2001. Chemiluminescence of luminol in the presence of iron(II) and oxygen: Oxidation mechanism and implications for its analytical use. Anal. Chem., 73: 5909-5920.
16. 12 in pharmaceuticals and human serum using flow injection with CL detection. Anal. Chim. Acta, 488: 71-79.
17. Triebel, M.M., Morozov, A.K., Totrov, M.M., and Zorinyants, G.E. 1993. Phase-on-frequency characteristics of the magnetic field effect for studying the mechanism of the branching chemiluminescent reaction of luminol. Chem. Phys. Lett., 214: 321-326.
18. El Walily, A.F.M., Razak, O.A., Belal, S.F., and Bakry, R.S. 1999. Utilization of carbon disulphide for the analytical determination of betahistine hydrochloride and captopril in their pharmaceutical preparations. J. Pharm. Biomed. Anal., 21: 439-449.